Trial Profile
Cell-mediated Immunity Study of H1N1 Influenza A Vaccine With Trivalent Inactivated Influenza Vaccine in Healthy Adults.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2013
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype; Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sinovac Biotech
- 01 Dec 2010 Status changed from recruiting to completed.
- 14 Nov 2009 New trial record